Drugtrade
Posted - 7 hours ago
$LTRN goes to zero or $100 no in between as always with bio...loaded 1k shares long
MBWallingford
Posted - 1 day ago
$LTRN this feels like a con. Slick CEO, Slick story. Don’t buy it. Go ahead post the hate. Just my opinion. Don’t like it just ignore.
intratio
Posted - 3 days ago
$LTRN https://www.intratio.com/stock-forecast/LTRN Lantern Pharma Inc. Our predictive algorithm judges this company s value has a poor setup for the immediate future and has no clear long-term directional perspective
crabbypatty31
Posted - 3 days ago
@thompske Of the 3 I sold today $LTRN was the hardest to let go but I just ran out of patience. Hard to keep holding when you are in the red for a long time and buyouts are pretty rare. I've only had that happen once and I've owned alot of biotechs - maybe just the wrong ones;)))
crabbypatty31
Posted - 3 days ago
@thompske A bit afraid to buy in now but will keep it on the watchlist for Monday am. Sold out of 3 biotechs today because they just keep getting shorted into oblivion. It's exhausting. I sold $GERN, $AKBA and $LTRN. Longs suffer and shorts prevail but I don't short stocks.:)) GLTA!
jheerdink
Posted - 6 days ago
$LTRN April’s Webinar Wednesday
April 24, 2024 – 1:00pm Eastern
"LP-300 in Never-Smokers with Non-small Cell Lung Cancer"
Register here: https://bit.ly/3vO117s
Join Joseph Treat, MD and Reggie Ewesuedo, MD to explore lung cancer in never-smokers, defining its uniqueness, challenges that patients are facing, and the successes and future of the Harmonic™ Phase 2 clinical trial for LP-300 in never-smokers with non-small cell lung cancer. https://finance.yahoo.com/news/lantern-pharma-launches-webinar-wednesdays-120000071.html
Stock_Titan
Posted - 6 days ago
$LTRN Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
https://www.stocktitan.net/news/LTRN/lantern-pharma-launches-webinar-wednesdays-featuring-world-class-x1iuovtte8jx.html
Bio_Be_Dirty
Posted - 6 days ago
$LTRN hmmm
tradingtwenty
Posted - 6 days ago
Top 5 after-hours stocks that have trended in the past 24 hours: $RXRX 14.03% 🔥 $AEYE 13.87% $TSLA 13.33% $CYN 8.33% $LTRN 8.32% Link: https://tradingtwenty.com/dashboard/trending/past
jheerdink
Posted - 6 days ago
$LTRN "Panna Sharma: AI to Transform Cancer Care and Usher in a New Era of Medicine" https://healthandpharma.net/panna-sharma-ai-cancer-care-medicine-artificial-intelligence
jheerdink
Posted - 1 week ago
$LTRN "Lantern Pharma Inc. (Nasdaq: LTRN) Pharma Inc. is proud to announce the expansion of our Harmonic™ trial into #Japan and #Taiwan, targeting non-small cell lung cancer (NSCLC) in never-smokers. Led by Dr. Yashushi Goto, a leading clinician-scientist from the National Cancer Center of Japan, this Phase 2 clinical study marks a significant step in addressing the needs of an often overlooked patient population in East Asia.
With approximately one-third of all lung cancer patients in East Asia being never-smokers, there is a pressing need for tailored treatment options. By evaluating the efficacy of LP-300 in combination with standard chemotherapy, we aim to provide hope and improved outcomes for never smoker patients with #NSCLC in Japan and Taiwan.
Check out the full story here
https://bit.ly/4b9K46t
#ClinicalTrial #CancerResearch
#Oncology #DrugDevelopment " https://www.linkedin.com/posts/lanternpharma_japan-taiwan-nsclc-activity-7188207939818516481-lhbA?utm_source=share&utm_medium=member_ios
mankind1
Posted - 1 week ago
$LTRN Time to load up
jheerdink
Posted - 1 week ago
$LTRN "Approximately 33% of all non-small cell lung cancer patients in East Asia are never smokers – a growing and unaddressed patient population." https://finance.yahoo.com/news/lantern-pharma-receives-regulatory-approval-121200177.html
jacckkmm
Posted - 1 week ago
$LTRN only 11 million shares outstanding? Oh yeah
DonCorleone77
Posted - 1 week ago
$LTRN Lantern Pharma receives regulatory approval to expand Harmonic trial Lantern Pharma announced that the company has received regulatory approval to expand its Harmonic trial, a Phase 2 clinical study evaluating LP-300 in non-small cell lung cancer, or NSCLC, in never-smokers in both Japan and Taiwan. Approximately one third of all lung cancer patients in East Asia are never-smokers and the proportion of lung cancer in never smokers, or LCINS, has been increasing gradually over time, according to a publication in Translational Lung Cancer Research. The approval to proceed with the Phase 2 clinical trials in Japan and Taiwan are expected to accelerate the collection of patient and response data needed for the next-stage of evaluation and development of LP-300, a therapeutic for the treatment of relapsed and inoperable primary adenocarcinoma of the lung given in combination with chemotherapy Additionally, it may also bring a needed therapeutic option for LCINS diagnosed patients in Japan and Taiwan, where one-third of all lung cancer diagnoses are made among those who have never smoked. Finally, Lantern believes that this improves the positioning for drug-candidate LP-300 to develop collaborative and co-development partnerships with global biopharma companies with a primary focus in serving the Asian markets.
jacckkmm
Posted - 1 week ago
$LTRN we run today…
Stock_Titan
Posted - 1 week ago
$LTRN Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
https://www.stocktitan.net/news/LTRN/lantern-pharma-receives-regulatory-approval-to-expand-harmonic-m942j7fsfb9o.html
jheerdink
Posted - 1 week ago
$LTRN "Our leadership in the innovative use of AI and machine learning to transform costs and timelines in the development of precision oncology therapies has guided three drug development programs in active clinical trials. We believe this pace of development with our focused team and resources should yield significant future benefits for investors and patients as our industry matures, adopts and accepts a data and AI-centric approach to drug development." https://finance.yahoo.com/news/lantern-pharma-inc-reports-progress-213202149.html
MBWallingford
Posted - 1 week ago
$LTRN weak, weak financial position. No sales for many years. This an idea right now. A crap shoot at best.
jheerdink
Posted - 1 week ago
$LTRN Financial Position: Strong cash position with $41.3 million in cash, cash equivalents, and marketable securities as of December 31, 2023. https://finance.yahoo.com/news/lantern-pharma-inc-reports-progress-213202149.html
MBWallingford
Posted - 1 week ago
$LTRN this one is floating in hot air. It maybe worth investing in one day, just not today.
jheerdink
Posted - 1 week ago
$LTRN Lantern Pharma is harnessing the power of AI and Machine Learning to Fight Cancer
Summary
This year, the United States expects to tally more than two million new cancer diagnoses— a first-ever prediction— and more than 611,000 cancer-related deaths. While the death rate from cancer is going down, largely due to improvements in early diagnosis and healthy lifestyle changes, the problem is that fewer people aren’t dying of cancer; that’s because the more people who are diagnosed, statistically the more who will die.
https://www.pharmiweb.com/article/lantern-pharma-is-harnessing-the-power-of-ai-and-machine-learning-to-fight-cancer
jheerdink
Posted - 2 weeks ago
$LTRN
DarthVestor
Posted - 2 weeks ago
$LTRN wow glad I waited. Gonna start buying back now.
dmed2021
Posted - 2 weeks ago
Joe Biden has destroyed the Economy 😡
$AMZN $LUNR $SOFI $LTRN $PLTR
jheerdink
Posted - 2 weeks ago
$LTRN Have you seen Think Equity's Report issued on Lantern today. It was titled "Lantern Pharma, Inc. (LTRN - $6.39 - BUY) Leverages AI to Disrupt Oncology Drug Development" Analyst Ashok Kumar, PHD, CFA